Synthesis and application of functional peptides as cell nucleus-directed molecules in the treatment of malignant diseases.
The unique functions of biomolecules, including transport across biological membranes (e.g. the cell membrane, the nuclear envelope), modulation of protein function, gene transcription, reconstitution of the malignant transformation, and viral, bacterial and fungal activities underlie a high pharmaceutical potential. The development of combinatorial functional peptide modules in this important area has been slow, in contrast to the rapid development in the synthesis of small biopolymers. The conjugation of a short transmembrane transport peptide module with a cell nucleus address peptide module and with any substance is attractive for preparation of BioShuttle-based peptides because of the well-established automated synthesis of peptides. Variation of the different functional modules for drug targeting and the choice of substances can be combined to create novel bioconjugates with unique properties. This article provides an overview of previous work on the BioShuttle technology and outlines the promising use of this approach in combinatorial peptide synthesis and drug discovery.
Pipkorn
R
R
German Cancer Research Center, Heidelberg, Germany. r.pipkorn@dkfz-heidelberg.de
Waldeck
W
W
Braun
K
K
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002467:Cell Nucleus / Q000187:drug effects*; D016503:Drug Delivery Systems; D005822:Genetic Vectors; D006367:HeLa Cells; D006801:Humans; D020014:K562 Cells; D009369:Neoplasms / Q000188:drug therapy*; D027383:Papillomaviridae; D010455:Peptides / Q000138:chemical synthesis* / Q000494:pharmacology
D000970:Antineoplastic Agents; D010455:Peptides